Can the Rheumatoid Arthritis (RA) factor be elevated in a patient with psoriatic arthritis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Rheumatoid Factor Be Elevated in Psoriatic Arthritis?

Yes, rheumatoid factor (RF) can be elevated in psoriatic arthritis, but this occurs in only a small minority of patients (approximately 3-22% depending on the study), and when present, it raises important diagnostic questions about whether the patient actually has rheumatoid arthritis rather than psoriatic arthritis. 1, 2, 3

Diagnostic Significance of RF in PsA

Rheumatoid factor negativity is a defining characteristic of psoriatic arthritis and is explicitly included in the CASPAR diagnostic criteria as one of the classification features. 4, 1 The fundamental distinction between PsA and RA relies on the absence of RF combined with specific clinical patterns of joint inflammation and the presence of psoriatic skin or nail lesions. 1

When RF is Detected in PsA Patients

The presence of RF in a patient with psoriasis and inflammatory arthritis should prompt careful reconsideration of the diagnosis:

  • RF positivity occurs in approximately 3% of PsA patients according to general estimates, though some studies report rates up to 22% in certain PsA subtypes. 2, 3

  • When RF is present in patients with psoriasis and polyarthritis, it may indicate the RA nature of the joint disease rather than true PsA. 2 This is particularly important because some patients may have coincidental RA and psoriasis occurring together rather than PsA.

  • Patients with RF-positive "PsA" tend to be older and have different joint involvement patterns, with greater involvement of metacarpophalangeal joints, elbow joints, and shoulder joints. 5

Clinical Patterns and RF Positivity

The relationship between RF and PsA varies by disease subtype:

  • In PsA type 1 (distal interphalangeal joint predominant), RF is essentially never detected. 2

  • In PsA type 3 (symmetric polyarthritis resembling RA), RF was found in 22% of patients in one study, suggesting diagnostic overlap or misclassification. 2

  • Some patients initially RF-positive later became RF-negative when sacroiliitis developed, suggesting the initial diagnosis may have been incorrect. 6

Practical Diagnostic Approach

When encountering a patient with psoriasis, inflammatory arthritis, and positive RF:

  1. Consider whether this represents true PsA with incidental RF positivity versus coincidental RA and psoriasis. 2, 6

  2. Evaluate for anti-CCP antibodies, which are more specific for RA. 5 When both RF and anti-CCP are positive in a patient with psoriasis and polyarthritis, RA is more likely than PsA.

  3. Assess the pattern of joint involvement: Symmetric small joint polyarthritis with RF positivity is more consistent with RA, while asymmetric oligoarthritis, DIP involvement, dactylitis, and enthesitis favor PsA even if RF is present. 4, 1, 5

  4. Look for characteristic PsA features that would support the diagnosis despite RF positivity: nail dystrophy (80-90% of PsA patients), dactylitis, enthesitis, and radiographic evidence of new bone formation. 4, 1

Important Caveats

The presence of RF should be considered an exclusion criterion for PsA diagnosis when accompanied by typical RA features, particularly symmetric polyarthritis without characteristic PsA manifestations like dactylitis, enthesitis, or DIP involvement. 2 However, low-level RF positivity can occasionally occur in true PsA and should not automatically exclude the diagnosis if other features strongly support PsA. 3, 5

A common pitfall is failing to recognize that some patients have both conditions simultaneously—true RA occurring in a patient who also has psoriasis—rather than PsA. 2, 6 This distinction has therapeutic implications, as treatment approaches may differ.

References

Guideline

Psoriatic Arthritis Classification and Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Clinical characteristics of psoriatic arthritis with positive rheumatoid factor or anti-cyclic citrullinated peptide antibody].

Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, 2019

Research

Rheumatoid type of psoriatic arthritis.

Clinical rheumatology, 1983

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.